Skip to content
10-Q

Quarterly Report

PASITHEA THERAPEUTICS CORP. KTTA KTTAW

0001213900-25-110093

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 7.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 5.12M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.04M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.04M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$9.81M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$11.48M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.12M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $6.92M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $9.36M
Stockholders Equity Q3 2025 · Sep 30, 2025 $12.21M
Stockholders Equity Q3 2025 · Jun 30, 2025 $15.18M
Stockholders Equity Q3 2025 · Mar 31, 2025 $12.98M
Stockholders Equity Q3 2025 · Dec 31, 2024 $14.78M
Stockholders Equity Q3 2025 · Sep 30, 2024 $17.81M
Stockholders Equity Q3 2025 · Jun 30, 2024 $16.18M
Stockholders Equity Q3 2025 · Mar 31, 2024 $19.88M
Stockholders Equity Q3 2025 · Dec 31, 2023 $23.4M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.38M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.12M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.42M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.28M
Current Assets Q3 2025 · Sep 30, 2025 $5.53M
Current Assets Q3 2025 · Dec 31, 2024 $7.37M
Total Assets Q3 2025 · Sep 30, 2025 $13.63M
Total Assets Q3 2025 · Dec 31, 2024 $16.06M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.41
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.02
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.87
Eps Diluted Q3 2025 · Sep 30, 2024 −$10.28
Eps Basic Q3 2025 · Sep 30, 2025 −$0.41
Eps Basic Q3 2025 · Sep 30, 2025 −$2.02
Eps Basic Q3 2025 · Sep 30, 2024 −$2.87
Eps Basic Q3 2025 · Sep 30, 2024 −$10.28
Rd Expense Q3 2025 · Sep 30, 2025 $1.36M
Rd Expense Q3 2025 · Sep 30, 2025 $5.24M
Rd Expense Q3 2025 · Sep 30, 2024 $1.58M
Rd Expense Q3 2025 · Sep 30, 2024 $5.69M
Net Income Q3 2025 · Sep 30, 2025 −$3.04M
Net Income Q3 2025 · Sep 30, 2025 −$10.32M
Net Income Q3 2025 · Jun 30, 2025 −$3.72M
Net Income Q3 2025 · Mar 31, 2025 −$3.56M
Net Income Q3 2025 · Sep 30, 2024 −$3M
Net Income Q3 2025 · Sep 30, 2024 −$10.73M
Net Income Q3 2025 · Jun 30, 2024 −$3.87M
Net Income Q3 2025 · Mar 31, 2024 −$3.86M
Operating Income Q3 2025 · Sep 30, 2025 −$3.11M
Operating Income Q3 2025 · Sep 30, 2025 −$10.6M
Operating Income Q3 2025 · Sep 30, 2024 −$3M
Operating Income Q3 2025 · Sep 30, 2024 −$10.99M